Director, New Products and Business Development, Hematology

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at jnj.com.

As guided by Our Credo, Johnson & Johnson is responsible to our employees who work with us throughout the world. We provide an inclusive work environment where each person is considered as an individual. At Johnson & Johnson, we respect the diversity and dignity of our employees and recognize their merit.

Job Function:

Strategy & Corporate Development

Job Sub Function:

Business Development

Job Category:

Professional

All Job Posting Locations:

Horsham, Pennsylvania, United States of America

Job Description:

Johnson and Johnson is recruiting for a Director, New Products & Business Development - Hematology to be located in Horsham, PA.

Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements. Visionaries like you work on teams that save lives by developing the medicines of tomorrow.

Our Oncology team is focused on the elimination of cancer by discovering new pathways and modalities to finding treatments and cures. We lead where medicine is going and need innovators with an unwavering commitment to results.

Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way.

Learn more at https://www.jnj.com/innovative-medicine

The Director, New Products & Business Development - Hematology will lead cross-functional US Integrated Strategy Teams and Launch Readiness to accelerate Johnson & Johnson Innovative Medicines' leadership in Hematology. The position is part of the US Hematology commercial organization.

The Director will focus initially on Launch Readiness for Bleximenib, an investigational, oral menin inhibitor being developed to treat acute myeloid leukemia (AML). The role currently reports to the US President of Hematology and will transition to reporting into the open Sr. Director US Hematology Therapeutic Area Lead (TAL).

Key Responsibilities:

New Product Strategy & Launch Readiness:

• Lead US Integrated Strategy Team (IST) to provide input into global compound strategy and Launch Readiness Team (LRT) as a core team member.

• Lead US strategic planning including positioning, value proposition, Go-To-Market strategy, and inform US label planning, competitive vision, TPP, and value proposition for products going through the investment governance process.

• Develop early market-shaping strategies including unbranded market development strategy, evidence generation, and KOL engagement.

• Own governance (Launch Challenge Sessions & Launch Readiness Reviews) for Launch Readiness Teams leveraging the Launch Excellence guidance document, tools & resources.

• Advise launch readiness team members on Launch Excellence Framework resources and providing feedback to shape continuous improvement of the Launch Excellence framework.

• Lead US strategic planning, including positioning, value proposition, and informing US label planning.

• Represent the US on the Global Commercial Team (GCT) to provide input to the Global Commercial Strategy Organization (GCSO).

• Partner with GCSO on pipeline assets to ensure commercial insight drives clinical development plans

• Collaborate with US NPBD Analytics to develop customer-insight-based forecasts and valuations to inform stage-gate decisions.

• Lead early launch planning to shape thinking and ensure project deliverables are current and relevant; identifies gaps, risks, and potential impact to timelines.

Business Development:

• Lead US input to select BD opportunities, including evaluation of competitive landscape, opportunity and required product attributes.

Key Competencies:

• Future-Oriented: Identify and und